JeffreyJohnMeyerMD

Radiation Oncology • Baltimore, MD

Associate Professor, Johns Hopkins

Join to view full profile

Dr. Meyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Meyer's full profile

Already have an account?

Office
401 North Broadway
Weinberg 1440
Baltimore, MD 21231
Phone+1 410-614-1642

Fax+1 410-933-1390

Education & Training

Duke University HospitalResidency, Radiation Oncology, 2004 - 2008
Cedars-Sinai Medical CenterInternship, Internal Medicine, 2003 - 2004
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003

Certifications & Licensure

MD State Medical License 2017 - 2025
DC State Medical License 2019 - 2024
TX State Medical License 2009 - 2024
NC State Medical License 2004 - 2022
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Stereotactic Body Radiation Therapy (SBRT) for Patients With Hepatic Metastases Start of enrollment: 2010 Jul 01
Completed
Phase 1
Circulating Tumor Cells in Prostate Cancer Patients Start of enrollment: 2011 Jul 01
Terminated
A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma Start of enrollment: 2012 Aug 08
Completed
Phase 1

Publications & Presentations

PubMed

2 citations
Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus.
Ted K Yanagihara, Joel E Tepper, Andrew M Moon, Aisling Barry, Meritxell Molla
Practical Radiation Oncology. 2024-01-19
98 citations
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline.
Smith Apisarnthanarax, Aisling Barry, Minsong Cao, Brian G. Czito, Ronald P. DeMatteo
Practical Radiation Oncology. 2021-09-25
147 citations
Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer
N.A. Cannon, Jeffrey J Meyer, Puneeth Iyengar, Chul Ahn, Kenneth D. Westover
Journal of Thoracic Oncology. 2015-02-01

Press Mentions

Stereotactic Radiation Highly Effective for Kidney CancerMay 4th, 2017